Recent Advances in Neuroblastoma

Por Maris, John M.
Publicado em 2010

A hidden Markov random field model for genome-wide association studies

Por Li, Hongzhe, Wei, Zhi, Maris, John
Publicado em 2010

New Strategies in Refractory and Recurrent Neuroblastoma: Translational Opportunities to Impact Patient Outcome

Por Cole, Kristina A., Maris, John M.
Publicado em 2012

Targeting MYCN: A Good BET for Improving Neuroblastoma Therapy?

Por Schnepp, Robert W., Maris, John M.
Publicado em 2013

Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations

Por Bosse, Kristopher R., Maris, John M.
Publicado no Cancer (2015)

Optimal False Discovery Rate Control for Dependent Data

Por Xie, Jichun, Cai, T. Tony, Maris, John, Li, Hongzhe
Publicado em 2011

High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma

Por Fredlund, Erik, Ringnér, Markus, Maris, John M., Påhlman, Sven
Publicado em 2008

Improving Patient Outcomes With Cancer Genomics: Unique Opportunities and Challenges in Pediatric Oncology

Por Schnepp, Robert W., Bosse, Kristopher R., Maris, John M.
Publicado no JAMA (2015)

The effectiveness of the antegrade reamed technique: the experience and complications from 415 traumatic femoral shaft fractures

Por Karadimas, Efthimios J., Papadimitriou, George, Theodoratos, Gerasimos, Papanikolaou, Anastasios, Maris, John
Publicado em 2009

CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation

Por Carlisle, Alex J, Lyttle, Christopher A, Carlisle, Rosalind Y, Maris, John M
Publicado em 2009

Genome-Wide Linkage Analysis to Identify Genetic Modifiers of ALK Mutation Penetrance in Familial Neuroblastoma

Por Devoto, Marcella, Specchia, Claudia, Laudenslager, Marci, Longo, Luca, Hakonarson, Hakon, Maris, John, Mossé, Yael
Publicado em 2011

Reply to N.-K.V. Cheung et al

Por Matthay, Katherine K., London, Wendy B., Maris, John, Adamson, Peter C., Park, Julie R.
Publicado no J Clin Oncol (2014)

Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma

Por Norris, Robin E., Minturn, Jane E., Brodeur, Garrett M., Maris, John M., Adamson, Peter C.
Publicado em 2011

Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1α

Por Qing, Guoliang, Skuli, Nicolas, Mayes, Patrick A., Pawel, Bruce, Martinez, Daniel, Maris, John M., Simon, M. Celeste
Publicado em 2010

Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans

Por Latorre, Valeria, Diskin, Sharon J., Diamond, Maura A., Zhang, Haitao, Hakonarson, Hakon, Maris, John M., Devoto, Marcella
Publicado em 2012

Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform

Por Maris, John M., Hii, George, Gelfand, Craig A., Varde, Shobha, White, Peter S., Rappaport, Eric, Surrey, Saul, Fortina, Paolo
Publicado em 2005

Germline PHOX2B Mutation in Hereditary Neuroblastoma

Por Mosse, Yael P., Laudenslager, Marci, Khazi, Deepa, Carlisle, Alex J., Winter, Cynthia L., Rappaport, Eric, Maris, John M.
Publicado em 2004

Initial Testing (Stage 1) of TAK-701, a humanized hepatocyte growth factor binding antibody, by the Pediatric Preclinical Testing Program

Por Houghton, Peter J., Kurmasheva, Raushan T., Kolb, E. Anders, Wu, Jianrong, Gorlick, Richard, Maris, John M., Smith, Malcolm A.
Publicado em 2013

TB-16 EXPLORATION OF eEF2K AS A NOVEL THERAPEUTIC TARGET IN MEDULLOBLASTOMA AND NEUROBLASTOMA

Por Delaidelli, Alberto, Khan, Debjit, Leprivier, Gabriel, Pfister, Stefan M., Taylor, Michael D., Maris, John M., Sorensen, Poul H.
Publicado no Neuro Oncol (2016)

Imaging genomics in cancer research: limitations and promises

Por Bai, Harrison X, Lee, Ashley M, Yang, Li, Zhang, Paul, Davatzikos, Christos, Maris, John M, Diskin, Sharon J
Publicado no Br J Radiol (2016)